Drug Shortage Report for APO-VALACYCLOVIR

Last updated on 2025-03-07

Report ID 230350
Drug Identification Number 02295822
Brand name APO-VALACYCLOVIR
Common or Proper name VALACYCLOVIR
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) VALACYCLOVIR
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 8 BLS
ATC code J05AB
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-06-12
Estimated end date 2025-03-21
Actual end date 2025-03-06
Shortage status Resolved
Updated date 2025-03-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2025-03-07 French Compare
v11 2025-03-07 English Compare
v10 2025-02-06 French Compare
v9 2025-02-06 English Compare
v8 2024-11-26 French Compare
v7 2024-11-26 English Compare
v6 2024-09-27 French Compare
v5 2024-09-27 English Compare
v4 2024-08-09 French Compare
v3 2024-08-09 English Compare
v2 2024-06-13 French Compare
v1 2024-06-13 English Compare

Showing 1 to 12 of 12